Bihl, F., Castelli, D. & Al. (2007), "transfusion-Transmitted Infections",

Gia Trung và trung tâm Giáo dục xã hội của Tây Nguyên", Tạp chí Y

học TP. Hồ Chí Minh, Tập 12(1), tr. 1-7.

36. Vũ Thị Tường Vân (2011), "Nghiên cứu nhiễm vi rút viêm gan C (HCV) ở người nghiện chích ma túy đến khám tại Bệnh viện Bạch Mai", Tạp chí Y học thực hành, Bộ Y tế, 768(6), tr. 145-148.

37. Abbas, Z. & al. (2011), "Management of hepatitis B in developing countries", World Hepatol. Journal, 3(12), pp. 292-299.

38. Aceijas, C. & al. (2004), "Global overview of injecting drug use and HIV infection among injecting drug users", AIDS journal, 18, pp. 2295- 2303.

39. Aceijas, C. & Rhodes, T. (2007), "Global estimates of prevalence of HCV infection among injecting drug users", Int. Drug Policy Jouranl, 18(5), pp. 352-8.

40. Alavian, S. M. & Fallahian, F. (2009), "Epidemiology of hepatitis C in Iran and the world", Shiraz E-Medical J., 10(4), pp. 1-13.

41. Alter, H. J. & Liang, T. J. (2012), "Hepatitis C: The End of the Beginning and Possibly the Beginning of the End", Annals of Internal Med. Journal, Vol. 156(4), pp. 317-319.

42. Alter, M. J. (2007), "Epidemiology of hepatitis c virus infection", World Gastroenterol. J., 13(17), pp. 2436-2441.

Có thể bạn quan tâm!

Xem toàn bộ 156 trang tài liệu này.

43. Alter, M. J. (2006), "Epidemiology of viral hepatitis and HIV- coinfection", Hepatology journal, 44, pp. S6-S9.

44. Aman, W. & al. (2012), "Current status and future directions in the management of chronic hepatitis C", Virology Journal, 9, pp. 57-78.

45. Anastassopoulou, C. G. & Kostrikis, L. G. (2006), "Global Genetic variation of HIV-1 infection", Current HIV Research Journal, Vol. 4(3), pp. 365-373.

46. Anbazhagan, G. K. & al. (2010), "Seroprevalence of HCV and its co- infection with HBV and HIV among liver disease patients ò South Tamil Nadu", W. Hepatology Journal, 2(1), pp. 42-48.

47. Archer, J. & Robertson, A. (2007), "Understanding the diversification of HIV-1 groups M and O", AIDS Journal, 21, pp. 1693-1700.

48. Aroldi, A. (2005), "Natural history of hepatitis B and C in renal allograft recipients", Transplantation Journal, 79, (9), pp. 1132.

49. Ashfaq, U. A. & al. (2011), "An overview of HCV molecular biology, replication and immune responses", Virology Journal, 8(161), pp. 1-10.

50. Attaullah, S., Khan, S., Ayaz, S. & al. (2011), "Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan", Virology Journal, 8, pp. 275-286.

51. Attaullah, S., Khan, S. & Khan, J. (2012), "Trend of transfusion transmitted infections frequency in blood donors: provide a road map for its prevention and control", Translational Medicine Journal, 10, pp. 20-24.

52. Ayesh, B. M., Zourob, S. & Abu-Jadallah, S. (2009), "Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional study", Virology Journal, 6, pp. 105.

53. Baral, S. & al. (2007), "Vaccine immunogenicity in injecting drug users: a systematic review", Lancet Infect. Dis. J., 7, pp. 667-74.

54. Bartosch, B. (2010), "Hepatitis B and C Viruses and Hepatocellular Carcinoma", Viiruses Journal, 2, pp. 1504-1509.

55. Belasio, E. F., Raimondo, M. & Butto, S. (2010), "HIV virology and pathogenesis mechanisms of infection: a brief overview", Ann Ist. Super Sanita J., Vol. 46(1), pp. 5-14.

56. Benhamou, Y. (2004), "Antiretroviral therapy and HIV/hepatitis B virus coinfection", Clin. Infect. Dis. J., 38 (2), pp. S98-103.

57. Bihl, F., Castelli, D. & al. (2007), "Transfusion-Transmitted infections",

Translational Medicine Journal, 5(25), pp. 1-11.

58. Bosevska, G., Kuzmanovska, G. & al. (2009), "Screening for hepatitis B, C and HIV infection among patients on haemodialysis." Contribution, Sec. Biol. Med. Sci. J., Vol. XXX(2), pp. 159-174.

59. Brook, G., Main, J., Nelson, M. & al. (2010), "British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010", HIV Medicine Journal, 11, pp. 1-30.

60. Brook, G., Soriano, V. & Bergin, C. (2010), "European guideline for the management of hepatitis B and C infections, 2010", Intern STD & AIDS Journal, 21, pp. 669-678.

61. Brook, M. G. (2006), "Prevention of viral hepatitis in HIV co-infection",

Hepatology Journal, 44, pp. S104-S107.

62. Buffington, J. & Jones, T. S. (2007), "Integrating Viral Hepatitis Prevention into Public Health Programs Serving People at High risk for Infection: Good Public Health ", Public Health Reports Journal, Vol. 122(Supp. 2), pp. 1-5.

63. Burban, S. D. & Yazdanpanah, Y. (2012), "It is Time to Change the Paradigm for Hepatitis C Virus Testing", Clinic. Infect. Dis. Journal, 54(9), pp. 1272-4.

64. Buskin, S. E. & al. (2011), "Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals", World Gastroenterol Journal, Vol. 17(14), pp. 1807-1816.

65. Butler, I. F., Pandrea, I. & Marx, P. A. (2007), "HIV Genetic Diversity: Biological and Public Health Consequences", Current HIV Research Journal, Vol. 5, pp. 23-45.

66. Cabibbo, G. & Craxi, A. (2010), "Epidemiology, risk factors and surveillance of hepatocellular carcinoma", Eur. Rev. Med. Pharmacol. Sci., 14, pp. 352-355.

67. Candotti, D. & Allain, J. P. (2009), "Transfusion-transmitted hepatitis B virus infection", Hepatology Journal, 51, pp. 798-809.

68. Chak, E., Talal, A. H. & Serman, K. E. (2011), "Hepatitis C virus infection in USA: an estimate of true prevalence", Liver International Journal, pp. 1090-1101.

69. Chao, D. T., Abe, K. & Nguyen, M. H. (2011), "Systematic review: epidemiology of hepatitis C genotype 6 and its management", Aliment. Phamacol. Ther. Journal, 34, pp. 286-296.

70. Chen, Y. J. & al. (2010), "Molercular Epidemiology of HIV-1 subtype B, CRF01_AE and CRF07_BC Infection among injection drug users in Taiwan", Acquir. Immune Defic. Sydr. Journal, 53(4), pp. 425-439.

71. Chiavetta, J. A., Escobar, M., Newman, A. & al. (2003), "Incidence and estimated rates of residual risk for HIV, hepatitis C hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990- 2000", Canada Medical A. J., 169(8), pp. 12-15.

72. Chinen, J. & Shearer, W. T. (2002), "Molecular virology and immunology of HIV infection ", Allergy Clin. Immunol. Journal, 110, pp. 189-98.

73. Chu, C. J. & Lee, S. D. (2008), "Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment", Gastroenterology and Hepatology Journal, 23(4), pp. 512- 520.

74. Cohen, M. S. & Gay, C. L. (2010), "Treatment to prevent transmission of HIV-1", Clin. Infect. Dis. Journal, 50(Suppl 3), pp. S85-95.

75. Demetriou, V. L. & al. (2010), "Hepatitis C Infection among Intravenous drug users attending therapy programs in Cyprus", Med. Virol. Journal, 82, pp. 263-270.

76. Drosten, C. & al. (2006), "Ultrasensitive Monitoring of HIV-1 Viral Load by a Low Cost Real-Time Reverse Transcription-PCR Assay with Internal Control for the 5' Long Terminal Repeat Domain", Clinical Chemistry Journal, 52(7), pp. 1258-1266.

77. Easterbrook, E. & al. (2010), "Impact of HIV-1 viral subtype on disease progression and response to antirestroviral therapy", The International AIDS Society Journal, 13, pp. 4.

78. Edey, M. & al. (2010), "Review article: Hepatitis B and dialysis",

Nephrology Journal, Vol.15, pp. 137-145.

79. Eida, M. (2010), "Chronic hepatitis C genotype 4 treatment in chronic haemodialysis patients: A restrospective study", Arab gastroenterology Journal, 11, pp. 83-87.

80. Eleftheriadis, T., Liakopoulos, V. & Leivaditis, K. (2011), "Infection in hemodialysis: a concise review. Part II: Blood transmitted viral infections", Hippokratia Journal, 15(2), pp. 120-126.

81. Elserag, H. B. (2011), "Hepatocellular carcinoma", New England Med. J.,

365, pp. 1118-27.

82. Espirito, M. P., Carneiro, M. A. S., Reis, N. R. S. & al. (2007), "Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis", Braz. Med. Biol. Res. Journal, 40, pp. 545-550.

83. Fabrizi, F. & Martin, P. (2008), "Transmission of hepatitis C virus in the hemodialysis setting", Hot Topics in Viral Hepatitis Journal, 11, pp. 13-18.

84. Fallahian, F., Najafi, A. & Alavian, S. M. (2010), "Intravenous Drug Use: the Predominant Risk Factors for Hepatitis C Virus Infection", Shoraz E- Medical J., 11, (4), pp. 4-14.

85. Filipowicz, M. S. (2010), "Interferon therapy of hepatitis C: Molecular insights into success and failure", Swiss Med. Weekly Journal, 140(1- 2), pp. 3-11.

86. Ford, N. & al. (2012), "Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS", Clinic. Infect. Dis. Journal, DOI: 10.1093/cid/cis227, pp. 1-8.

87. Franchini, M. & al. (2002), "Update on chronic hepatitis C in hemophiliacs", Haematological Journal, 87, pp. 542-549.

88. Franchini, M. & al. (2008), "Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis", Antimicrobial Chemotherapy Journal, 61, pp. 1191-1200.

89. Franco, E. & al. (2012), "Hepatitis B: Epidemiology and prevention in developing countries", World J. Hepatol., Vol. 4(3), pp. 74-80.

90. Galetto, R. & Negroni, M. (2005), "Mechanistic Features of recombination in HIV", AIDS Reviews Journal, Vol.7, pp. 92-102.

91. Garcia-Calleja, J. M., Gouws, E. & Ghys, P. D. (2006), "National population based HIV prevalence surveys in sub-Saharan Africa: result and omplications for HIV and AIDS estimates", Sex. Transm. Infect. Journal, 82, pp. iii64-iii70.

92. Garson, J. A. & al. (2005), "Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control", Clinical Virology Journal, 126, pp. 207-213.

93. Gordon, C. E., Uhlig, K. & Lau, J. (2009), "Interferon for Hepatitis C Virus in Hemodialysis-an Individual Patients Meta-analysis of Factors

Associated with Sustained Virological Response." Clin. Am. Soc. Nephrol. Journal, 4, pp. 1449-1458.

94. Gutierrez, M., Tajada, P., Alvarez, A. & al. (2004), "Prevalence of HIV-1 non-B subtypes, Syphilis, HTLV and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain", Med. Virol. Journal, 74(4), pp. 521-7.

95. Hagan, H. (2011), "Agent, Host, and En vironment: Hepatitis C Virus in People who Inject Drugs", IInfect. Dis. Journal, 204, pp. 1819-21.

96. Hagan, H., Pouget, E. R. & Jarlais J.C (2011), "A Systematic Review and Meta-Analysis of Intervention to Prevent Hepatitis C virus Infection in People Who Inject Drugs", Infectious Diseases Journal, 204, pp. 74-83.

97. Hamissi, J. & Hamissi, H. (2011), "Occurence of hepatitis B and C infection among hemodialyzed patients with chronic renal failure in Qazvin, Iran: A preliminary study", Int. J. of Coll. Res. on Inter. Med. & Pub. Health, Vol. 3(1), pp. 88-96.

98. Han, L. & Wang, S. (2010), "Hepatitis C viral infection in a Chinese hemodialysis unit", Chin. Med. Journal, 123(24), pp. 3574-3577.

99. Harnois, D. M. (2012), "Hepatitis C virus Infection and the rising Incidence of Hepatocellular Carcinoma", MayoClin. Proc. Journal, 87(1), pp. 7-8.

100. Hellard, M., Davis, R. S. & Gold, J. (2009), "Hepatitis C treatment for Injection drug users: A review of the available evidence", Clinic. Infect. Dis. Journal, 49, pp. 561-73.

101. Hemelaar, J., Gouws, E. & Ghys, P. D. (2006), "Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004", AIDS journal, 20, pp. W13 - W23.

102. Higgs, P. & al. (2011), "Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence", Hepat. Mon. Journal, 11(7), pp. 513-518.

103. Hnatyszyn, H. J. (2005), "Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes", Antivir. Ther. Journal, 10(1), pp. 1-11.

104. Holguín, A. & al. (2000), "Recombinant Human Immunodeficiency Viruses Type 1 Circulating in Spain", AIDS Res. and Human Retrovir. Journal, 16(5), pp. 505-511.

105. Hosseini-Moghaddam, S. M. & al. (2006), "Distribution of hepatitis c virus genotypes among hemodialysis patients in Teheran multicenter study", Medical Virology Journal, Vol. 78(5), pp. 569-573.

106. Hou, J. L., Liu, Z. & Gu, F. (2005), "Epidemiology and Prevention of Hepatitis B Virus Infection", Intn'. Med. Sci. Journal, 2(1), pp. 50-57.

107. Hwang, E. W. & Cheung, R. (2011), "Global Epidemiology of Hepatitis B Virus (HBV) Infection", Nor. A. of Med. and Sciences Journal (NAJMS) 4(1), pp. 7-13.

108. Jacobson, I. M., Davis, G. L. & Serag, H. E. (2010), "Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection", Clin. Gastroenterol. and Hepat. Journal, 8, pp. 924- 933.

109. Jarlais, C. D. & Semaan, S. (2008), "HIV prevention for Injecting Drug Users: The First 25 Years and Counting", Psychosomatic Medicine Journal, 70, pp. 606-611.

110. Jasuja, S. & Gupta, A. K. (2009), "Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital", Indian Nephrology Journal, 19(2), pp. 62-67.